FI117160B - Nestemäiset HCG-koostumukset - Google Patents

Nestemäiset HCG-koostumukset Download PDF

Info

Publication number
FI117160B
FI117160B FI973745A FI973745A FI117160B FI 117160 B FI117160 B FI 117160B FI 973745 A FI973745 A FI 973745A FI 973745 A FI973745 A FI 973745A FI 117160 B FI117160 B FI 117160B
Authority
FI
Finland
Prior art keywords
hcg
rec
liquid pharmaceutical
mannitol
buffer
Prior art date
Application number
FI973745A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973745A0 (fi
FI973745A (fi
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Priority to FI973745A priority Critical patent/FI117160B/fi
Publication of FI973745A0 publication Critical patent/FI973745A0/fi
Publication of FI973745A publication Critical patent/FI973745A/fi
Application granted granted Critical
Publication of FI117160B publication Critical patent/FI117160B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Semiconductor Memories (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Cosmetics (AREA)
FI973745A 1995-03-21 1997-09-22 Nestemäiset HCG-koostumukset FI117160B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI973745A FI117160B (fi) 1995-03-21 1997-09-22 Nestemäiset HCG-koostumukset

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/EP1995/001055 WO1996029095A1 (en) 1995-03-21 1995-03-21 Hcg liquid formulations
EP9501055 1995-03-21
FI973745 1997-09-22
FI973745A FI117160B (fi) 1995-03-21 1997-09-22 Nestemäiset HCG-koostumukset

Publications (3)

Publication Number Publication Date
FI973745A0 FI973745A0 (fi) 1997-09-22
FI973745A FI973745A (fi) 1997-11-11
FI117160B true FI117160B (fi) 2006-07-14

Family

ID=8165977

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973745A FI117160B (fi) 1995-03-21 1997-09-22 Nestemäiset HCG-koostumukset

Country Status (16)

Country Link
US (1) US6706681B1 (ja)
EP (1) EP0814841B1 (ja)
JP (1) JP4165718B2 (ja)
KR (1) KR100377967B1 (ja)
AT (1) ATE209930T1 (ja)
AU (1) AU707796B2 (ja)
BR (1) BR9510567A (ja)
DE (1) DE69524456T2 (ja)
DK (1) DK0814841T3 (ja)
ES (1) ES2166841T3 (ja)
FI (1) FI117160B (ja)
HK (1) HK1006365A1 (ja)
NO (1) NO318997B1 (ja)
PT (1) PT814841E (ja)
UA (1) UA61053C2 (ja)
WO (1) WO1996029095A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
EA001579B1 (ru) * 1997-01-30 2001-06-25 Хехст Марион Рассел Лтд. Лиофилизированная композиция морфогенетического фактора роста кости мр52 человека и способ её получения
SK287146B6 (sk) 2000-02-22 2010-01-07 Laboratoires Serono Sa Spôsob prípravy rekombinantného choriogonadotropínu - hCG zo vzorky
WO2002011753A1 (fr) * 2000-08-04 2002-02-14 Chugai Seiyaku Kabushiki Kaisha Preparations proteiniques a injecter
FR2869979B1 (fr) * 2004-05-06 2006-08-04 Packinox Sa Echangeur thermique a plaques
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
KR20080106636A (ko) * 2007-06-04 2008-12-09 동아제약주식회사 사람 융모성 성선자극호르몬 함유 즉시 사용형 주사 용액
DK2219607T3 (da) * 2007-11-01 2013-06-17 Merck Serono Sa Flydende LH-formuleringer
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2011108010A2 (en) * 2010-03-05 2011-09-09 Intas Biopharmaceuticals Limited A thermostable liquid formulation of gonadotropins
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
BR112015008753A2 (pt) 2012-10-18 2017-07-04 Neuralight Hd Llc tratamento de depressão e ptsd

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5385230A (en) * 1991-01-11 1995-01-31 Minnesota Mining And Manufacturing Company Adjustable tray assembly for use in desk drawers
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.

Also Published As

Publication number Publication date
NO318997B1 (no) 2005-05-30
UA61053C2 (en) 2003-11-17
JP4165718B2 (ja) 2008-10-15
ES2166841T3 (es) 2002-05-01
PT814841E (pt) 2002-03-28
KR19980702859A (ko) 1998-08-05
AU2110695A (en) 1996-10-08
DK0814841T3 (da) 2002-03-04
EP0814841A2 (en) 1998-01-07
HK1006365A1 (en) 1999-02-26
DE69524456T2 (de) 2002-08-01
US6706681B1 (en) 2004-03-16
EP0814841B1 (en) 2001-12-05
JPH11502205A (ja) 1999-02-23
NO974309D0 (no) 1997-09-18
AU707796B2 (en) 1999-07-22
BR9510567A (pt) 1998-06-23
DE69524456D1 (de) 2002-01-17
NO974309L (no) 1997-10-14
KR100377967B1 (ko) 2003-06-12
WO1996029095A1 (en) 1996-09-26
FI973745A0 (fi) 1997-09-22
FI973745A (fi) 1997-11-11
ATE209930T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
FI117160B (fi) Nestemäiset HCG-koostumukset
Österberg et al. Development of a freeze-dried albumin-free formulation of recombinant factor VIII SQ
FI112169B (fi) Menetelmä ihmisproteiinipitoisten infuusio- tai injektointitarkoituksiin tarkoitettujen säilöttyjen lääkkeiden valmistamiseksi
US5650390A (en) Gonadotropin containing pharmaceutical compositions with sucrose stabilizer
CA2713386C (en) Liquid formulation of fsh
EP1308170B1 (en) Dried blood factor composition comprising trehalose
EP0448146B1 (en) Stabilized gonadotropin containing preparations
US20010051603A1 (en) Dried blood factor composition comprising trehalose
KR100624013B1 (ko) 동결건조된 알부민 비함유 재조합 사람 혈액응고 제 8인자 제제
EP1641486B1 (en) Stable, aqueous solution of human erythropoietin, not containing serum albumin
SK862004A3 (en) Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
US7767644B2 (en) Erythropoietin liquid formulation
US20050202091A1 (en) Stable pharmaceutical composition comprising erythropoietin
RU2160605C2 (ru) Жидкие композиции, содержащие человеческий хорионический гонадотропин (hcg)
SI21257A (sl) Stabilni farmacevtski pripravek, ki vsebuje eritropoietin
US20030139468A1 (en) Amiodarone solutions suitable for intravenous administration

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117160

Country of ref document: FI

SPCF Supplementary protection certificate application filed

Spc suppl protection certif: L20070002

Spc suppl protection certif: L20070003

PC Transfer of assignment of patent

Owner name: LABORATOIRES SERONO SA

Free format text: LABORATOIRES SERONO SA

SPCL Withdrawal, rejection or dismissal of a supplementary protection certificate

Free format text: SPC L20070002

Spc suppl protection certif: L20070002

Free format text: SPC L20070003

Spc suppl protection certif: L20070003

PC Transfer of assignment of patent

Owner name: MERCK SERONO SA

Free format text: MERCK SERONO SA

MA Patent expired